Bright Minds Biosciences Inc. (DRUG)
Nasdaq: DRUG · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2020
Who runs Bright Minds Biosciences Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
0
of 3 people with a filing in the last fifteen months
Directors reporting now
0
3 people on the record since 2024
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chen Bihua | 10% owner | Oct 2024 | Apr 30, 2026 | none |
| Cormorant Asset Management, LP | 10% owner | Oct 2024 | Apr 30, 2026 | 1 · $9.8M |
| Cormorant Global Healthcare Master Fund, LP | 10% owner | Oct 2024 | Apr 30, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.